Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$802M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$440M |
| 3 |
Meta Platforms (Facebook)
META
|
+$400M |
| 4 |
Uber
UBER
|
+$389M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$257M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.71B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$613M |
| 3 |
Apple
AAPL
|
+$478M |
| 4 |
Mastercard
MA
|
+$450M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$424M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.12% |
| 2 | Financials | 2.35% |
| 3 | Healthcare | 2.22% |
| 4 | Consumer Discretionary | 2.21% |
| 5 | Communication Services | 1.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VERV
1926
DELISTED
Verve Therapeutics
VERV
| $20.2M | ﹤0.01% |
547,210
-119,174
| -18% | -$5.01M |
|
|
RBAC
1927
DELISTED
RedBall Acquisition Corp.
RBAC
| $20.2M | ﹤0.01% |
2,032,929
+1,836,779
| +936% | +$18.4M |
|
1928
Vroom Inc
VRM
$56.8M
| $20.2M | ﹤0.01% |
23,360
+14,292
| +158% | +$19.2M |
|
1929
CALL
QuantumScape Corp
QS
$3.81B
| $20.1M | ﹤0.01% |
908,000
-1,007,800
| -53% | -$27.6M |
|
1930
PUT
Ferrari
RACE
$72.9B
| $20.1M | ﹤0.01% |
77,800
-45,000
| -37% | -$11.1M |
|
1931
CALL
Copart
CPRT
$29.3B
| $20.1M | ﹤0.01% |
531,200
-240,800
| -31% | -$8.94M |
|
1932
Schwab Short-Term US Treasury ETF
SCHO
$13B
| $20.1M | ﹤0.01% |
+791,022
| New | +$20.2M |
|
|
CNDA
1933
DELISTED
Concord Acquisition Corp II
CNDA
| $20.1M | ﹤0.01% |
+2,061,720
| New | +$20.2M |
|
1934
CALL
Corpay
CPAY
$27.4B
| $20.1M | ﹤0.01% |
89,700
+48,000
| +115% | +$11.5M |
|
1935
iShares Core MSCI Emerging Markets ETF
IEMG
$159B
| $20.1M | ﹤0.01% |
+335,262
| New | +$20.7M |
|
|
1936
Ferrari
RACE
$72.9B
| $20.1M | ﹤0.01% |
77,514
+9,175
| +13% | +$2.26M |
|
1937
CALL
AvalonBay Communities
AVB
$26.3B
| $20.1M | ﹤0.01% |
79,400
-77,800
| -49% | -$18.6M |
|
1938
CALL
Scotiabank
BNS
$112B
| $20.1M | ﹤0.01% |
279,700
+193,900
| +226% | +$12.8M |
|
|
ABMD
1939
PUT
DELISTED
Abiomed Inc
ABMD
| $20M | ﹤0.01% |
55,800
-10,900
| -16% | -$3.68M |
|
1940
Bank of Montreal
BMO
$130B
| $20M | ﹤0.01% |
185,868
-9,742
| -5% | -$1.05M |
|
|
EXAS
1941
DELISTED
Exact Sciences
EXAS
| $20M | ﹤0.01% |
256,982
-317,189
| -55% | -$28M |
|
1942
CALL
APA Corp
APA
$14.2B
| $20M | ﹤0.01% |
743,400
-434,500
| -37% | -$11.5M |
|
1943
Merit Medical Systems
MMSI
$5.42B
| $20M | ﹤0.01% |
320,609
+294,011
| +1,105% | +$19.7M |
|
1944
CALL
Celsius Holdings
CELH
$7.36B
| $20M | ﹤0.01% |
803,100
+103,200
| +15% | +$2.86M |
|
1945
ICU Medical
ICUI
$4.58B
| $19.9M | ﹤0.01% |
83,841
+13,530
| +19% | +$3.16M |
|
1946
Oracle
ORCL
$434B
| $19.9M | ﹤0.01% |
228,108
+185,900
| +440% | +$17.5M |
|
|
KNTE
1947
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $19.9M | ﹤0.01% |
1,121,704
-32,569
| -3% | -$687K |
|
|
MRSH
1948
PUT
Marsh
MRSH
$89.6B
| $19.9M | ﹤0.01% |
114,300
+15,700
| +16% | +$2.61M |
|
|
HUT
1949
Hut 8
HUT
$10.5B
| $19.9M | ﹤0.01% |
506,157
+459,262
| +979% | +$25.8M |
|
|
RKTA
1950
DELISTED
Rocket Internet Growth Opportunities Corp.
RKTA
| $19.8M | ﹤0.01% |
2,024,191
+1,048,176
| +107% | +$10.2M |
|
Similar funds
Ken Griffin's Q4 2021 Portfolio in Review
As of Q4 2021, Ken Griffin held 15,615 positions worth $489B, up 1.7% from $481B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Ken Griffin withdrew a net $30B in Q4 2021, closing 1,910 positions and reducing 6,339 holdings. Its most notable exit was CIMAREX ENERGY CO, an estimated $279M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 3.1% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Ken Griffin opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $248M.
- Ken Griffin's largest Q4 2021 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,847,920 shares worth $248M.
- Ken Griffin added most to Amazon in Q4 2021, an estimated $802M increase.
- Ken Griffin's biggest Q4 2021 reduction was Tesla, cutting an estimated $1.71B.
- Ken Griffin fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $279M.
- Ken Griffin's ten largest holdings make up 29% of its $489B portfolio in Q4 2021.
- Ken Griffin opened 1,894 new positions and closed 1,910 in Q4 2021.
- Ken Griffin's portfolio value rose 1.7% quarter-over-quarter to $489B.
Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.